The Amyloidosis Forum – bringing together the AL amyloidosis community with FDA
ARC is excited to announce the inaugural gathering of The Amyloidosis Forum on November 12, 2019 at FDA’s White Oak Campus in Silver Spring, MD. (more…)
Data sharing. It is an important topic and there is a real need for it in our community. Data sharing encourages more connection and collaboration among researchers, which can result in important new findings within the field. (more…)
For the third year running, ARC is supporting a CME Satellite Symposium at the Heart Failure Society of America (HFSA) conference. "Avoiding the pitfalls of diagnosing and treating cardiac ATTR amyloidosis" will be held on Sunday evening, September 15, at...
Publication of cardiac ATTR amyloidosis diagnosis guidelines
ARC-supported consensus best practices guidelines for the diagnosis of cardiac ATTR amyloidosis published in the journal of the American Heart Association, Circulation:Heart Failure. (more…)
Opportunity to Advance hATTR Amyloidosis Research from Home
Prothena has teamed up with Sanguine, a provider of at-home clinical research services, to give you the opportunity to help advance hATTR Amyloidosis research from home. (more…)
Join our email list to stay up to date on the latest Amyloidosis news.
In this ARC talks webinar, Alicia Lawrence, Information and Resource Services Manager at the National Organization for Rare Disorders (NORD), discussed health insurance policies within private and government issued insurance.
In addition to discussing policies regarding appeals, prior authorization, and law changes by state, Alicia provides guidance for application submissions with key tips and deadlines to remember.
Original Presentation Date:
September 28, 2023
Key Webinar Highlights:
0:00 — Introduction
3:40 — Start of presentation
5:37 — Types of insurance
7:10 — Parts of Medicare
9:45 — Choosing the right health insurance
Definitions of:
Premiums
Deductibles
Co-pays
Co-insurance
12:44 — Considerations when re-applying for coverage